Phylogenetic metrics can separate two complementary biodiversity dimensions: the amount of evolutionary history retained in a community (Faith's phylogenetic diversity, PD) and community assembly signals expressed as departures from null expectations in phylogenetic relatedness (standardized effect size of mean pairwise phylogenetic distance, SES.MPD). However, at the individual-forest scale-where conservation and management decisions are implemented-the key drivers and linked pathways controlling these two dimensions often remain unclear. Here, PD and SES.MPD were quantified for 96 20 × 20 m forest plots spanning broadleaved, conifer, and subalpine forests on Mt. Gariwang, South Korea. Community phylogenies were generated and related to elevation, stand age class, soil fertility, species richness, and community-weighted mean (CWM) traits (specific leaf area, SLA; wood density, WD) using information-theoretic multimodel inference and piecewise structural equation modeling. PD and SES.MPD differed significantly among forest types, but were governed by distinct controls. PD was most strongly and negatively associated with CWM.WD, indicating that dominance by high-wood-density strategies coincided with reduced retained evolutionary history. In contrast, SES.MPD was primarily negatively associated with CWM.SLA and species richness, with soil fertility influencing SES.MPD indirectly via SLA; stand age class showed limited explanatory power. Overall, these results demonstrate decoupled drivers of evolutionary-history retention versus assembly-related coexistence structure and identify management-relevant levers at the individual-forest scale, highlighting the importance of trait dominance and soil-trait pathways in addition to forest type.
{"title":"Decoupled Drivers of Phylogenetic Diversity and Community Assembly Signals Across Forest Types in a Temperate Forest, South Korea.","authors":"Chang-Bae Lee","doi":"10.3390/life16020301","DOIUrl":"10.3390/life16020301","url":null,"abstract":"<p><p>Phylogenetic metrics can separate two complementary biodiversity dimensions: the amount of evolutionary history retained in a community (Faith's phylogenetic diversity, PD) and community assembly signals expressed as departures from null expectations in phylogenetic relatedness (standardized effect size of mean pairwise phylogenetic distance, SES.MPD). However, at the individual-forest scale-where conservation and management decisions are implemented-the key drivers and linked pathways controlling these two dimensions often remain unclear. Here, PD and SES.MPD were quantified for 96 20 × 20 m forest plots spanning broadleaved, conifer, and subalpine forests on Mt. Gariwang, South Korea. Community phylogenies were generated and related to elevation, stand age class, soil fertility, species richness, and community-weighted mean (CWM) traits (specific leaf area, SLA; wood density, WD) using information-theoretic multimodel inference and piecewise structural equation modeling. PD and SES.MPD differed significantly among forest types, but were governed by distinct controls. PD was most strongly and negatively associated with CWM.WD, indicating that dominance by high-wood-density strategies coincided with reduced retained evolutionary history. In contrast, SES.MPD was primarily negatively associated with CWM.SLA and species richness, with soil fertility influencing SES.MPD indirectly via SLA; stand age class showed limited explanatory power. Overall, these results demonstrate decoupled drivers of evolutionary-history retention versus assembly-related coexistence structure and identify management-relevant levers at the individual-forest scale, highlighting the importance of trait dominance and soil-trait pathways in addition to forest type.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":"16 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12942560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Despite the global increase in cat ownership, some cats exhibit owner-directed aggression, resulting in caregiver injury, infection, and anxiety. Severe cases are commonly treated with selective serotonin reuptake inhibitors such as fluoxetine; however, adverse effects, particularly transient anorexia, often discourage treatment initiation. Cannabidiol (CBD), a natural compound with reported anxiolytic properties and minimal anorexic effects, may represent an alternative therapy. This study aimed to characterise owner-directed feline aggression in Thailand, identify associated factors, and compare the efficacy of CBD with fluoxetine. Most caregivers were females aged 20-40 years, and most cats were neutered mixed-breeds aged 1-6 years living indoors in multi-human and multi-cat households. For demographic variables, only human-cat interactions (e.g., petting) were significantly associated with aggression. Handling-induced aggression was universal, with grooming as the most common trigger (56%). In a single-blind, 4-8-week trial, 100 cats were randomly assigned to control, CBD 1 mg/kg/day, CBD 2 mg/kg/day, fluoxetine 0.5-1 mg/kg/day, or combined CBD and fluoxetine. Aggression scores decreased significantly in all treatment groups compared with control (p < 0.05), with no differences among active treatments. CBD at 1 mg/kg/day showed efficacy comparable to fluoxetine without anorexic effects.
{"title":"Owner-Directed Feline Aggression in Thailand: Characteristics, Associated Factors, and a Clinical Comparison of Treatments.","authors":"Jarawee Supanta, Worakan Boonhoh, Orachun Hayakijkosol, Tuempong Wongtawan","doi":"10.3390/life16020307","DOIUrl":"10.3390/life16020307","url":null,"abstract":"<p><p>Despite the global increase in cat ownership, some cats exhibit owner-directed aggression, resulting in caregiver injury, infection, and anxiety. Severe cases are commonly treated with selective serotonin reuptake inhibitors such as fluoxetine; however, adverse effects, particularly transient anorexia, often discourage treatment initiation. Cannabidiol (CBD), a natural compound with reported anxiolytic properties and minimal anorexic effects, may represent an alternative therapy. This study aimed to characterise owner-directed feline aggression in Thailand, identify associated factors, and compare the efficacy of CBD with fluoxetine. Most caregivers were females aged 20-40 years, and most cats were neutered mixed-breeds aged 1-6 years living indoors in multi-human and multi-cat households. For demographic variables, only human-cat interactions (e.g., petting) were significantly associated with aggression. Handling-induced aggression was universal, with grooming as the most common trigger (56%). In a single-blind, 4-8-week trial, 100 cats were randomly assigned to control, CBD 1 mg/kg/day, CBD 2 mg/kg/day, fluoxetine 0.5-1 mg/kg/day, or combined CBD and fluoxetine. Aggression scores decreased significantly in all treatment groups compared with control (<i>p</i> < 0.05), with no differences among active treatments. CBD at 1 mg/kg/day showed efficacy comparable to fluoxetine without anorexic effects.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":"16 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12942625/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Peter Racioppo, Ziyuan Chris Wang, SriniVas R Sadda, Zhihong Jewel Hu
Age-related macular degeneration (AMD) is the leading cause of central vision loss in aging populations. Geographic atrophy (GA) is the advanced, non-neovascular form of AMD. Predicting the longitudinal progression of GA remains a critical challenge in ophthalmic clinical practice and clinical trial design. Forecasting the trajectory of GA is complicated by highly variable growth rates and the inherent scarcity of long-term, high-quality imaging data. To address these challenges, we introduce the Sliding Window Attention U-Net (SWAU-Net), a hybrid architecture that integrates Transformer-based temporal modeling of GA growth with precise spatial modeling of GA location with a U-Net convolutional neural network (CNN). To ensure generalization in the low-data regime, SWAU-Net embeds explicit temporal and geometric consistency priors via a weight-shared Sliding Window Attention core and feature-level regularization that preserves sparse, high-frequency lesion boundaries across frames. Experimental results demonstrate that these structural constraints prevent the model from overfitting to imaging noise, achieving a Growth Mask Dice Similarity Coefficient (DSC) of 0.66 (representing the spatial overlap between the predicted and ground truth lesion expansion regions), a significant improvement over unregularized Transformer and standard recurrent baseline models. Our framework provides a robust tool for predicting GA lesion trajectories, potentially supporting more efficient clinical trial designs and personalized patient monitoring.
{"title":"SWAU-Net: Longitudinal Prediction of Geographic Atrophy via Sliding-Window Attention.","authors":"Peter Racioppo, Ziyuan Chris Wang, SriniVas R Sadda, Zhihong Jewel Hu","doi":"10.3390/life16020303","DOIUrl":"10.3390/life16020303","url":null,"abstract":"<p><p>Age-related macular degeneration (AMD) is the leading cause of central vision loss in aging populations. Geographic atrophy (GA) is the advanced, non-neovascular form of AMD. Predicting the longitudinal progression of GA remains a critical challenge in ophthalmic clinical practice and clinical trial design. Forecasting the trajectory of GA is complicated by highly variable growth rates and the inherent scarcity of long-term, high-quality imaging data. To address these challenges, we introduce the Sliding Window Attention U-Net (SWAU-Net), a hybrid architecture that integrates Transformer-based temporal modeling of GA growth with precise spatial modeling of GA location with a U-Net convolutional neural network (CNN). To ensure generalization in the low-data regime, SWAU-Net embeds explicit temporal and geometric consistency priors via a weight-shared Sliding Window Attention core and feature-level regularization that preserves sparse, high-frequency lesion boundaries across frames. Experimental results demonstrate that these structural constraints prevent the model from overfitting to imaging noise, achieving a Growth Mask Dice Similarity Coefficient (DSC) of 0.66 (representing the spatial overlap between the predicted and ground truth lesion expansion regions), a significant improvement over unregularized Transformer and standard recurrent baseline models. Our framework provides a robust tool for predicting GA lesion trajectories, potentially supporting more efficient clinical trial designs and personalized patient monitoring.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":"16 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12941623/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
David Aebisher, Klaudia Dynarowicz, Izabela Rudy, Kacper Rogóż, Dorota Bartusik-Aebisher, Aleksandra Kawczyk-Krupka
Nanobiotechnology, defined as the application of nanotechnology in biology and medicine, refers to the use of nanometric structures to solve complex clinical problems through precise interaction at the molecular level. Nanostructures such as lipid, polymer, and metallic nanoparticles offer unique properties that enable improved therapeutic and diagnostic efficacy and the integration of diagnostic and therapeutic functions within the concept of theranostics. Major applications of nanobiotechnology include targeted drug delivery in cancer, infection, and gene therapy; advanced molecular diagnostics and biosensors; tissue engineering and regeneration; and immune system modulation through modern nanotechnology-based vaccines and immunotherapies. The clinical significance of these technologies lies in their ability to improve drug bioavailability, minimize adverse effects, increase sensitivity in early disease detection, and support personalized treatment strategies. Nanobiotechnology also contributes to the development of precision medicine by combining diagnostics and therapy within a single nanosystem. Despite promising results, significant challenges remain related to safety, biocompatibility, toxicity, and translation from laboratory studies to clinical applications. Further research is needed to standardize methods, assess the long-term health impact of nanomaterials, and develop regulatory frameworks to fully realize the potential of nanobiotechnology in medicine.
{"title":"Applications of Nanobiotechnology in Medicine.","authors":"David Aebisher, Klaudia Dynarowicz, Izabela Rudy, Kacper Rogóż, Dorota Bartusik-Aebisher, Aleksandra Kawczyk-Krupka","doi":"10.3390/life16020302","DOIUrl":"10.3390/life16020302","url":null,"abstract":"<p><p>Nanobiotechnology, defined as the application of nanotechnology in biology and medicine, refers to the use of nanometric structures to solve complex clinical problems through precise interaction at the molecular level. Nanostructures such as lipid, polymer, and metallic nanoparticles offer unique properties that enable improved therapeutic and diagnostic efficacy and the integration of diagnostic and therapeutic functions within the concept of theranostics. Major applications of nanobiotechnology include targeted drug delivery in cancer, infection, and gene therapy; advanced molecular diagnostics and biosensors; tissue engineering and regeneration; and immune system modulation through modern nanotechnology-based vaccines and immunotherapies. The clinical significance of these technologies lies in their ability to improve drug bioavailability, minimize adverse effects, increase sensitivity in early disease detection, and support personalized treatment strategies. Nanobiotechnology also contributes to the development of precision medicine by combining diagnostics and therapy within a single nanosystem. Despite promising results, significant challenges remain related to safety, biocompatibility, toxicity, and translation from laboratory studies to clinical applications. Further research is needed to standardize methods, assess the long-term health impact of nanomaterials, and develop regulatory frameworks to fully realize the potential of nanobiotechnology in medicine.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":"16 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12941592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ensuring a sustainable source of nutritious food is critical for long-duration space missions. Thai landrace rice 466HM exhibits high nutritional value and stress resilience, making it a promising candidate for space cultivation, yet its response to low Earth orbit (LEO) conditions remains poorly understood. This study compared rice grains maintained under terrestrial conditions with grains stored aboard the Shijian-19 (SJ-19) reusable satellite, orbiting at ~336 km for 13.5 days under microgravity (2-7 × 10-7g) and an absorbed radiation dose of ~0.153 rad (Si). Volatile compound profiling, texture analysis of cooked grains, and simulated gastrointestinal digestion followed by peptide mass fingerprinting were performed. LEO-exposed rice grains exhibited a 1.67-fold increase in adhesiveness compared to Earth-based rice (p < 0.01), while hardness remained unchanged between the two groups (p > 0.05), alongside distinct alterations in flavor-related volatile compounds and peptide profiles. Principal component analysis revealed clear separation between Earth and LEO-exposed samples, indicating microgravity-associated shifts in digestible peptide composition. Cytotoxicity assessment using MTT assays in HT-29 and HepG2 cells confirmed the safety of both rice types. These findings demonstrate that orbital conditions influence the compositional, functional, and sensory attributes of rice, providing insights relevant to space agriculture and astronaut nutrition.
确保可持续的营养食物来源对长期太空任务至关重要。泰国地方稻466HM具有很高的营养价值和抗逆性,是空间栽培的有希望的候选者,但其对低地球轨道(LEO)条件的响应尚不清楚。本研究比较了在陆地条件下保存的稻谷与在实践19号(SJ-19)可重复使用卫星上储存的稻谷,实践19号在微重力(2-7 × 10-7g)下在336公里轨道运行13.5天,吸收辐射剂量为~0.153 rad (Si)。进行了挥发性化合物分析、煮熟谷物的质地分析、模拟胃肠道消化以及肽质量指纹图谱分析。与地球大米相比,暴露于低氧环境下的大米的黏附性增加了1.67倍(p < 0.01),而硬度在两组之间保持不变(p < 0.05),同时与风味相关的挥发性化合物和肽谱也发生了明显的变化。主成分分析显示,暴露在地球和低氧环境下的样品之间存在明显的差异,表明微重力相关的可消化肽组成发生了变化。用MTT法对HT-29和HepG2细胞进行细胞毒性评估,证实了这两种水稻类型的安全性。这些发现表明,轨道条件影响水稻的成分、功能和感官属性,为太空农业和宇航员营养提供了相关见解。
{"title":"Foodomics of Rice Grains in Astrobiology: Spaceflight-Induced Modulation of Aroma, Texture, and Protein Digestibility in Thai Landrace Rice (466HM) Aboard the Shijian-19 (SJ-19) Low Earth Orbit Mission.","authors":"Tatpong Tulyananda, Yodying Yingchutrakul, Kakanang Tantraphongsathon, Atiggamas Khamsuwan, Peerapon Moung-Ngam, Phanchita Vejchasarn, Phakorn Papan, Jakkaphan Kumsab, Chutikarn Butkinaree, Sithichoke Tangphatsornruang, Meng Chieh Yang, Arnatchai Maiuthed, Sittiporn Channumsin, Sucheewin Krobthong","doi":"10.3390/life16020299","DOIUrl":"10.3390/life16020299","url":null,"abstract":"<p><p>Ensuring a sustainable source of nutritious food is critical for long-duration space missions. Thai landrace rice 466HM exhibits high nutritional value and stress resilience, making it a promising candidate for space cultivation, yet its response to low Earth orbit (LEO) conditions remains poorly understood. This study compared rice grains maintained under terrestrial conditions with grains stored aboard the Shijian-19 (SJ-19) reusable satellite, orbiting at ~336 km for 13.5 days under microgravity (2<sup>-7</sup> × 10<sup>-7</sup><i>g</i>) and an absorbed radiation dose of ~0.153 rad (Si). Volatile compound profiling, texture analysis of cooked grains, and simulated gastrointestinal digestion followed by peptide mass fingerprinting were performed. LEO-exposed rice grains exhibited a 1.67-fold increase in adhesiveness compared to Earth-based rice (<i>p</i> < 0.01), while hardness remained unchanged between the two groups (<i>p</i> > 0.05), alongside distinct alterations in flavor-related volatile compounds and peptide profiles. Principal component analysis revealed clear separation between Earth and LEO-exposed samples, indicating microgravity-associated shifts in digestible peptide composition. Cytotoxicity assessment using MTT assays in HT-29 and HepG2 cells confirmed the safety of both rice types. These findings demonstrate that orbital conditions influence the compositional, functional, and sensory attributes of rice, providing insights relevant to space agriculture and astronaut nutrition.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":"16 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12941713/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Obesity is a major health problem in developed countries and a growing one in the developing world [...].
肥胖在发达国家是一个主要的健康问题,在发展中国家也是一个日益严重的问题。
{"title":"New Updates in Adipocytes and Adipose Tissue.","authors":"Endre Kristóf, Éva Csősz","doi":"10.3390/life16020300","DOIUrl":"10.3390/life16020300","url":null,"abstract":"<p><p>Obesity is a major health problem in developed countries and a growing one in the developing world [...].</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":"16 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12941797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Artur Dziadkiewicz, Krzysztof Pawłowski, Anna Podlasek, Michał Sulkowski, Krzysztof Gawrych, Marek Szołkiewicz
<p><p>(1) Introduction. To improve access times and provide effective treatment to the growing patient population with acute stroke due to large vessel occlusion (LVO), thrombectomy-capable stroke centers (TCSCs) should be made an integral part of hospital infrastructure in Poland. The geographical proximity of thrombectomy-capable centers and recently extended treatment time windows will considerably increase patient numbers, decrease patient disability, and reduce the costs of long-term care. (2) Aim of the study. This study investigates the clinical outcomes, time metrics, and angiographic data of a cohort containing 250 thrombectomy patients at a single TCSC in Poland. We measured performance against data from the national database during two crucial time intervals: at the very beginning of the center's service and after the involvement of a new operator. This study considers concurrent modifications in qualification guidelines, the TCSC's transition from a 'direct-admission-only' to a 'drip-and-ship' model, and the learning curve of the interventional stroke team. (3) Methods. A retrospective analysis was conducted on 250 patients treated from August 2020 to May 2025 at a newly established TCSC. The cohort was dived into 2 subgroups: an initial group of 100 patients, whose treatment corresponded to the involvement of a new, previously trained on-site operator and the establishment of 24/7 service, and a group of 150 patients who received later treatment. Additional comparisons were made between a cohort of directly admitted patients and those treated under the drip-and-ship model. The results compared between patients treated with early and expanded time windows. (4) Results. Significant differences were observed between the first 100 and subsequent 150 patients in terms of admission scheme (97% vs. 70%, <i>p</i> < 0.0001), extended time window treatment (8% vs. 17.3%, <i>p</i> < 0.05), and intravenous thrombolysis treatment (81% vs. 65.3%, <i>p</i> < 0.01). Improvements in time intervals and procedural factors were noted in the second group, reflecting the operator's increased experience (groin-to-first pass time: 27 vs. 23 min, <i>p</i> < 0.05). A comparative analysis between the direct admission and drip-and-ship models revealed extended time intervals in the latter (door-to-groin: 110 vs. 159 min, <i>p</i> < 0.001; door-to-recanalization: 158 vs. 200 min, <i>p</i> < 0.001; door-to-CT: 9 vs. 16.5 min, <i>p</i> < 0.001; and door-to-IVT: 21 vs. 43 min, <i>p</i> < 0.001). Patients in the extended time window exhibited lower intravenous thrombolysis rates (78.2% vs. 29.4%, <i>p</i> < 0.0001) and prolonged door-to-groin (117.5 vs. 150 min, <i>p</i> < 0.005), door-to-CT (10 vs. 19.5 min, <i>p</i> < 0.01), and door-to-IVT (25 vs. 77.5 min, <i>p</i> < 0.001) times. No significant differences were found in complication rates, clinical outcomes, or mortality between the analyzed subgroups. (5) Conclusions. The present data demonstrate favorable cli
(1)介绍。为了改善就诊时间,并为不断增长的因大血管闭塞(LVO)导致的急性卒中患者提供有效治疗,应将血栓切除术卒中中心(TCSCs)作为波兰医院基础设施的一个组成部分。血栓切除中心的地理位置邻近以及最近延长的治疗时间窗口将大大增加患者数量,减少患者残疾,并降低长期护理的成本。(2)研究目的。本研究调查了波兰一个TCSC的250例取栓患者的临床结果、时间指标和血管造影数据。我们根据国家数据库的数据在两个关键时间间隔内测量了性能:在中心服务开始时和在新操作员参与之后。本研究考虑了资质指南的同步修改,TCSC从“只接收直接”到“输送”模式的转变,以及介入卒中团队的学习曲线。(3)方法。回顾性分析了2020年8月至2025年5月在新成立的TCSC接受治疗的250例患者。该队列被分为两个亚组:第一组有100名患者,他们的治疗对应于一名新的,以前受过培训的现场操作员的参与和24/7服务的建立,另一组有150名患者接受后来的治疗。在一组直接入院的病人和那些在滴船模式下治疗的病人之间进行了额外的比较。结果比较了早期和扩大时间窗治疗的患者。(4)结果。前100例患者与随后的150例患者在入院方案(97%对70%,p < 0.0001)、延长时间窗治疗(8%对17.3%,p < 0.05)和静脉溶栓治疗(81%对65.3%,p < 0.01)方面存在显著差异。第二组的时间间隔和程序因素有所改善,反映了操作员经验的增加(腹股沟到第一次通过时间:27分钟vs. 23分钟,p < 0.05)。直接入路和滴入-船模式的比较分析显示,后者的时间间隔延长(门到腹股沟:110分钟vs. 159分钟,p < 0.001;门到再通:158分钟vs. 200分钟,p < 0.001;门到ct: 9分钟vs. 16.5分钟,p < 0.001;门到ivt: 21分钟vs. 43分钟,p < 0.001)。延长时间窗的患者静脉溶栓率较低(78.2% vs. 29.4%, p < 0.0001),门静脉到腹股沟(117.5 vs. 150 min, p < 0.005)、门静脉到ct (10 vs. 19.5 min, p < 0.01)和门静脉到ivt (25 vs. 77.5 min, p < 0.001)时间延长。在分析的亚组之间,在并发症发生率、临床结果或死亡率方面没有发现显著差异。(5)结论。目前的数据表明,在新成立的TCSC,无论是在机械取栓服务开始时还是在新培训的操作员参与后,急性左心室卒中患者的临床和血管造影结果都很好。即使在治疗由于运输和晚窗资格而延长时间的患者时,我们也观察到良好的临床结果和低并发症发生率。我们在TCSC中获得的结果与国家数据进行了比较,表明TCSC可能在波兰急性缺血性卒中患者的整个血管内治疗系统中发挥重要作用。
{"title":"Technical and Clinical Outcomes at a Thrombectomy-Capable Stroke Center in Poland in the Context of the Center's Growing Experience, Expanding Treatment Guidelines and the Rise in Acute Ischemic Stroke Patient Volume: A Comparative Analysis of Initial and Subsequent Endovascular Procedures.","authors":"Artur Dziadkiewicz, Krzysztof Pawłowski, Anna Podlasek, Michał Sulkowski, Krzysztof Gawrych, Marek Szołkiewicz","doi":"10.3390/life16020304","DOIUrl":"10.3390/life16020304","url":null,"abstract":"<p><p>(1) Introduction. To improve access times and provide effective treatment to the growing patient population with acute stroke due to large vessel occlusion (LVO), thrombectomy-capable stroke centers (TCSCs) should be made an integral part of hospital infrastructure in Poland. The geographical proximity of thrombectomy-capable centers and recently extended treatment time windows will considerably increase patient numbers, decrease patient disability, and reduce the costs of long-term care. (2) Aim of the study. This study investigates the clinical outcomes, time metrics, and angiographic data of a cohort containing 250 thrombectomy patients at a single TCSC in Poland. We measured performance against data from the national database during two crucial time intervals: at the very beginning of the center's service and after the involvement of a new operator. This study considers concurrent modifications in qualification guidelines, the TCSC's transition from a 'direct-admission-only' to a 'drip-and-ship' model, and the learning curve of the interventional stroke team. (3) Methods. A retrospective analysis was conducted on 250 patients treated from August 2020 to May 2025 at a newly established TCSC. The cohort was dived into 2 subgroups: an initial group of 100 patients, whose treatment corresponded to the involvement of a new, previously trained on-site operator and the establishment of 24/7 service, and a group of 150 patients who received later treatment. Additional comparisons were made between a cohort of directly admitted patients and those treated under the drip-and-ship model. The results compared between patients treated with early and expanded time windows. (4) Results. Significant differences were observed between the first 100 and subsequent 150 patients in terms of admission scheme (97% vs. 70%, <i>p</i> < 0.0001), extended time window treatment (8% vs. 17.3%, <i>p</i> < 0.05), and intravenous thrombolysis treatment (81% vs. 65.3%, <i>p</i> < 0.01). Improvements in time intervals and procedural factors were noted in the second group, reflecting the operator's increased experience (groin-to-first pass time: 27 vs. 23 min, <i>p</i> < 0.05). A comparative analysis between the direct admission and drip-and-ship models revealed extended time intervals in the latter (door-to-groin: 110 vs. 159 min, <i>p</i> < 0.001; door-to-recanalization: 158 vs. 200 min, <i>p</i> < 0.001; door-to-CT: 9 vs. 16.5 min, <i>p</i> < 0.001; and door-to-IVT: 21 vs. 43 min, <i>p</i> < 0.001). Patients in the extended time window exhibited lower intravenous thrombolysis rates (78.2% vs. 29.4%, <i>p</i> < 0.0001) and prolonged door-to-groin (117.5 vs. 150 min, <i>p</i> < 0.005), door-to-CT (10 vs. 19.5 min, <i>p</i> < 0.01), and door-to-IVT (25 vs. 77.5 min, <i>p</i> < 0.001) times. No significant differences were found in complication rates, clinical outcomes, or mortality between the analyzed subgroups. (5) Conclusions. The present data demonstrate favorable cli","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":"16 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12941616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Idiopathic pulmonary fibrosis represents a chronic, progressive, lethal lung disease of various etiologies exerting a dramatic impact on patients' survival and quality of life. Its increasing prevalence and high mortality rates indicate the importance of early diagnosis and management involving the assessment of specific comorbidities, such as lung cancer. Emerging evidence suggests that in the context of IPF, lung scarring may be a potential risk factor for lung cancer development. Both disease entities present pathogenic commonalities including genetic and epigenetic markers, signaling pathways and cell transformation obtaining mesenchymal phenotypes. Beyond understanding disease pathogenesis, anti-cancer drugs such as nintedanib have been successfully used to treat patients with IPF. Additionally, a therapeutic approach that includes a mix of various pleiotropic anti-fibrotic agents is currently being developed for IPF treatment. Currently, there is no consensus on the application of therapeutic algorithms in concurrent pulmonary fibrosis and lung tumors. This review summarizes the current state of knowledge on common cellular and molecular pathogenetic mechanisms of IPF and lung cancer and highlights potential therapeutic targets with fruitful results.
{"title":"The Fibrotic-Cancer Continuum in IPF: Shared Mechanisms, Clinical Implications and Therapeutic Challenges.","authors":"Panagiota Tsiri, Marousa Kouvela, Ourania Papaioannou, Vasilina Sotiropoulou, Matthaios Katsaras, Nikolaos Syrigos, Fotios Sampsonas, Argyrios Tzouvelekis","doi":"10.3390/life16020295","DOIUrl":"10.3390/life16020295","url":null,"abstract":"<p><p>Idiopathic pulmonary fibrosis represents a chronic, progressive, lethal lung disease of various etiologies exerting a dramatic impact on patients' survival and quality of life. Its increasing prevalence and high mortality rates indicate the importance of early diagnosis and management involving the assessment of specific comorbidities, such as lung cancer. Emerging evidence suggests that in the context of IPF, lung scarring may be a potential risk factor for lung cancer development. Both disease entities present pathogenic commonalities including genetic and epigenetic markers, signaling pathways and cell transformation obtaining mesenchymal phenotypes. Beyond understanding disease pathogenesis, anti-cancer drugs such as nintedanib have been successfully used to treat patients with IPF. Additionally, a therapeutic approach that includes a mix of various pleiotropic anti-fibrotic agents is currently being developed for IPF treatment. Currently, there is no consensus on the application of therapeutic algorithms in concurrent pulmonary fibrosis and lung tumors. This review summarizes the current state of knowledge on common cellular and molecular pathogenetic mechanisms of IPF and lung cancer and highlights potential therapeutic targets with fruitful results.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":"16 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12941835/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maarja Randväli, Kaja Mädamürk, Jekaterina Šteinmiller, Toomas Toomsoo
Background: Type 2 diabetes mellitus (T2DM) is associated with increased vulnerability to depression and other affective disturbances, potentially mediated by neurobiological alterations in the serotonergic brainstem raphe nuclei. This study examined whether raphe hypoechogenicity, assessed by transcranial sonography, is associated with depressive, anxiety, and sleep-related symptoms in individuals with T2DM, and whether such alterations are linked to diabetes-related complications.
Methods: This cross-sectional study included 230 participants with T2DM and non-diabetic controls. Raphe echogenicity was assessed using transcranial sonography (TCS), and mental health outcomes were measured with the Patient Health Questionnaire 9 (PHQ-9) and the Emotional Well-Being Questionnaire (EWQ). To address demographic imbalance, analyses were repeated in a propensity score-adjusted subsample (n = 89).
Results: Raphe hypoechogenicity was associated with higher insomnia scores (EWQ6; β = 0.67, p = 0.01); however, this association was attenuated to non-significance after adjustment for sleep medication use and did not survive correction for multiple comparisons, and no associations were observed with PHQ-9 or other EWQ subscales. The participants with hypoechogenic raphe also exhibited a higher prevalence of other diabetes-related complications (32% vs. 7%, p = 0.03).
Conclusions: In this exploratory cross-sectional sample, reduced raphe echogenicity was not associated with overall depressive or anxiety symptom severity, but was associated with higher self-reported sleep-related symptom burden. However, this association was not robust to adjustment for sleep medication use or to correction for multiple comparisons. These findings are hypothesis-generating and require replication in larger, longitudinal and medication-naive cohorts using standardized sleep instruments.
{"title":"Brainstem Raphe Echogenicity and Insomnia in Type 2 Diabetes: An Exploratory Cross-Sectional Study.","authors":"Maarja Randväli, Kaja Mädamürk, Jekaterina Šteinmiller, Toomas Toomsoo","doi":"10.3390/life16020298","DOIUrl":"10.3390/life16020298","url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes mellitus (T2DM) is associated with increased vulnerability to depression and other affective disturbances, potentially mediated by neurobiological alterations in the serotonergic brainstem raphe nuclei. This study examined whether raphe hypoechogenicity, assessed by transcranial sonography, is associated with depressive, anxiety, and sleep-related symptoms in individuals with T2DM, and whether such alterations are linked to diabetes-related complications.</p><p><strong>Methods: </strong>This cross-sectional study included 230 participants with T2DM and non-diabetic controls. Raphe echogenicity was assessed using transcranial sonography (TCS), and mental health outcomes were measured with the Patient Health Questionnaire 9 (PHQ-9) and the Emotional Well-Being Questionnaire (EWQ). To address demographic imbalance, analyses were repeated in a propensity score-adjusted subsample (n = 89).</p><p><strong>Results: </strong>Raphe hypoechogenicity was associated with higher insomnia scores (EWQ6; β = 0.67, <i>p</i> = 0.01); however, this association was attenuated to non-significance after adjustment for sleep medication use and did not survive correction for multiple comparisons, and no associations were observed with PHQ-9 or other EWQ subscales. The participants with hypoechogenic raphe also exhibited a higher prevalence of other diabetes-related complications (32% vs. 7%, <i>p</i> = 0.03).</p><p><strong>Conclusions: </strong>In this exploratory cross-sectional sample, reduced raphe echogenicity was not associated with overall depressive or anxiety symptom severity, but was associated with higher self-reported sleep-related symptom burden. However, this association was not robust to adjustment for sleep medication use or to correction for multiple comparisons. These findings are hypothesis-generating and require replication in larger, longitudinal and medication-naive cohorts using standardized sleep instruments.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":"16 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12942166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Radoslaw Parma, Radoslaw Gocol, Joanna Nawara-Skipirzepa, Ryszard Bachowski, Wojciech Wojakowski, Damian Hudziak
Background: Inadvertent arterial cannulation during central venous catheter placement is a recognized complication with potentially serious consequences, particularly when involving large-caliber catheters. While management strategies have evolved from mandatory surgical repair to various percutaneous approaches, limited data exist regarding collagen-based vascular closure devices for large-bore carotid arteriotomies. Case Presentation: We report the case of a 59-year-old male patient with acute Stanford Type A aortic dissection who underwent emergency surgical repair of the ascending aorta. During central venous cannulation, a five-lumen Certofix Quinto catheter (12-French outer diameter) was inadvertently inserted into the left common carotid artery. Given the complexity of concurrent cardiac surgery and the large-bore nature of the arteriotomy, percutaneous closure with an 18-French MANTA vascular closure device was successfully performed following completion of the aortic repair. The procedure achieved immediate hemostasis without complications. Outcomes: The patient remained neurologically intact throughout a 12-month follow-up period. Serial duplex ultrasonography and computed tomography angiography confirmed carotid artery patency without evidence of stenosis, dissection, pseudoaneurysm formation, or thromboembolic complications. Conclusions: This case demonstrates the technical feasibility of using a collagen-based vascular closure device for percutaneous management of a large-bore carotid arteriotomy in the acute surgical setting. While the outcome was favorable in this patient, this approach represents an off-label application that requires further validation and should be reserved for carefully selected cases in experienced centers where the benefits of percutaneous closure are judged to outweigh the uncertainties of supra-aortic device deployment.
{"title":"Percutaneous Closure of a Large-Bore Carotid Arteriotomy Using a Collagen-Based Vascular Plug.","authors":"Radoslaw Parma, Radoslaw Gocol, Joanna Nawara-Skipirzepa, Ryszard Bachowski, Wojciech Wojakowski, Damian Hudziak","doi":"10.3390/life16020292","DOIUrl":"10.3390/life16020292","url":null,"abstract":"<p><p><b>Background</b><b>:</b> Inadvertent arterial cannulation during central venous catheter placement is a recognized complication with potentially serious consequences, particularly when involving large-caliber catheters. While management strategies have evolved from mandatory surgical repair to various percutaneous approaches, limited data exist regarding collagen-based vascular closure devices for large-bore carotid arteriotomies. <b>Case Presentation:</b> We report the case of a 59-year-old male patient with acute Stanford Type A aortic dissection who underwent emergency surgical repair of the ascending aorta. During central venous cannulation, a five-lumen Certofix Quinto catheter (12-French outer diameter) was inadvertently inserted into the left common carotid artery. Given the complexity of concurrent cardiac surgery and the large-bore nature of the arteriotomy, percutaneous closure with an 18-French MANTA vascular closure device was successfully performed following completion of the aortic repair. The procedure achieved immediate hemostasis without complications. <b>Outcomes:</b> The patient remained neurologically intact throughout a 12-month follow-up period. Serial duplex ultrasonography and computed tomography angiography confirmed carotid artery patency without evidence of stenosis, dissection, pseudoaneurysm formation, or thromboembolic complications. <b>Conclusions:</b> This case demonstrates the technical feasibility of using a collagen-based vascular closure device for percutaneous management of a large-bore carotid arteriotomy in the acute surgical setting. While the outcome was favorable in this patient, this approach represents an off-label application that requires further validation and should be reserved for carefully selected cases in experienced centers where the benefits of percutaneous closure are judged to outweigh the uncertainties of supra-aortic device deployment.</p>","PeriodicalId":56144,"journal":{"name":"Life-Basel","volume":"16 2","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12942100/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147312956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}